Yüklüyor......
What do oncologists need to know about biosimilar products?
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of...
Kaydedildi:
| Yayımlandı: | Chin J Cancer |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062853/ https://ncbi.nlm.nih.gov/pubmed/27733189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0151-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|